Development of novel polymeric micellar drug conjugates and nano-containers with hydrolyzable core structure for doxorubicin delivery

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 69, Issue 3, 2008, Pages 923-934

  Mahmud, Abdullah ^a   Xiong, Xiao Bing ^a   Lavasanifar, Afsaneh ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cytotoxicity; Doxorubicin; Poly(ethylene oxide) block poly( caprolactone); Polymer drug conjugate; Polymeric micelles

Indexed keywords

BENZYL DERIVATIVE; CARBOXYL GROUP; COPOLYMER; DOXORUBICIN; POLY(ETHYLENE OXIDE CO EPSILON CAPROLACTONE); POLY(ETHYLENE OXIDE EPSILON CAPROLACTONE CO ALPHA BENZYLCARBOXYLATE EPSILON CAPROLACTONE); POLYESTER; POLYMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHEMICAL STRUCTURE; CONJUGATE; DEGRADATION; DIALYSIS MEMBRANE; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENCAPSULATION; GEL PERMEATION CHROMATOGRAPHY; HYDROLYSIS; IC 50; IN VITRO STUDY; MELANOMA CELL; MICELLE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PH; SYNTHESIS;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL SURVIVAL; CHROMATOGRAPHY, GEL; DOXORUBICIN; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; ELECTROCHEMISTRY; HYDROLYSIS; MELANOMA, EXPERIMENTAL; MICE; MICELLES; NANOPARTICLES; PARTICLE SIZE; POLYESTERS; POLYMERS; TETRAZOLIUM SALTS; THIAZOLES;

EID: 48149115510     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2008.02.021     Document Type: Article

References (45)

1. Aliabadi H.M., and Lavasanifar A. Expert Opin. Drug Deliv. 3 (2006) 139-162
2. Gaucher G., Dufresne M.H., Sant V., Kang N., Maysinger D., and Leroux J. J. Control. Release 109 (2005) 169-188
3. A. Mahmud, X.B. Xiong, H.M. Aliabadi, A. Lavasanifar, J. Drug Target., in press.
4. Nakanishi T., Fukushima S., Okamoto K., Suzuki M., Matsumura Y., Yokoyama M., Okano T., Sakurai Y., and Kataoka K. J. Control. Release 74 (2001) 295-302
5. Lavasanifar A., Samuel J., Sattari S., and Kwon G.S. Pharm. Res. 19 (2002) 418-422
6. Li Y., and Kwon G.S. Pharm. Res. 17 (2000) 607-611
7. Yokoyama M., Satoh A., Sakurai Y., Okano T., Matsumura Y., Kakizoe T., and Kataoka K. J. Control. Release 55 (1998) 219-229
8. Nishiyama N., Yokoyama M., Aoyaga T., Okano T., Sakurai Y., and Kataoka K. Langmuir 15 (1999) 377-383
9. Katayose S., and Kataoka K. Bioconjug. Chem. 8 (1997) 702-707
10. Oishi M., Nagasaki Y., Itaka K., Nishiyama N., and Kataoka K. J. Am. Chem. Soc. 127 (2005) 1624-1625
11. Mahmud A., Xiong X.B., and Lavasanifar A. Macromolecules 39 (2006) 9419-9428
12. Yoo H.S., Lee E.A., and Park T.G. J. Control. Release 82 (2002) 17-27
13. Yoo H.S., Lee K.H., Oh J.E., and Park T.G. J. Control. Release 68 (2000) 419-431
14. Yoo H.S., Oh J.E., Lee K.H., and Park T.G. Pharm. Res. 16 (1999) 1114-1118
15. Yoo H.S., and Park T.G. J. Control. Release 70 (2001) 63-70
16. Zhao C.L., Winnik M.A., Riess G., and Croucher M.D. Langmuir 6 (1990) 514-516
17. Lavasanifar A., Samuel J., and Kwon G.S. Colloids Surf. B Biointerfaces 22 (2001) 115-126
18. Tomlinson R., Heller J., Brocchini S., and Duncan R. Bioconjug. Chem. 14 (2003) 1096-1106
19. Kwon G., Naito M., Yokoyama M., Okano T., Sakurai Y., and Kataoka K. Langmuir 9 (1993) 945-949
20. Jeong Y.I., Cheon J.B., Kim S.H., Nah J.W., Lee Y.M., Sung Y.K., Akaike T., and Cho C.S. J. Control. Release 51 (1998) 169-178
21. Georges J. Spectrochim. Acta Rev. 13 (1990) 27-45
22. Shuai X., Ai H., Nasongkla N., Kim S., and Gao J. J. Control. Release 98 (2004) 415-426
23. Maeda H. Adv. Drug Deliv. Rev. 46 (2001) 169-185
24. Muggia F.M. Clin. Cancer Res. 5 (1999) 7-8
25. Xu R.L., Winnik M.A., Hallett F.R., Riess G., and Croucher M.D. Macromolecules 24 (1991) 87-93
26. La S.B., Okano T., and Kataoka K. J. Pharm. Sci. 85 (1996) 85-90
27. Kang N., and Leroux J.C. Polymer 45 (2004) 8967-8980
28. Allen C., Yu Y., Maysinger D., and Eisenberg A. Bioconjug. Chem. 9 (1998) 564-572
29. De Jaeghere F., Allemann E., Leroux J.C., Stevels W., Feijen J., Doelker E., and Gurny R. Pharm. Res. 16 (1999) 859-866
30. Yokoyama M., Fukushima S., Uehara R., Okamoto K., Kataoka K., Sakurai Y., and Okano T. J. Control. Release 50 (1998) 79-92
31. Geng Y., and Discher D.E. J. Am. Chem. Soc. 127 (2005) 12780-12781
32. Pitt C.G., Chasalow F.I., Hibionada Y.M., Klimas D.M., and Schindler A. J. Appl. Polym. Sci. 26 (1981) 3779-3787
33. Pitt C.G., Gratzl M.M., Kimmel G.L., Surles J., and Schindler A. Biomaterials 2 (1981) 215-220
34. Sung H.J., Meredith C., Johnson C., and Galis Z.S. Biomaterials 25 (2004) 5735-5742
35. Gimenez S., Ponsart S., Coudane J., and Vert M. J. Bioactive Compatible Polym. 16 (2001) 32-46
36. Tsuji H., Kidokoro Y., and Mochizuki M. Macromol. Mater. Eng. 291 (2006) 1245-1254
37. Seib F.P., Jones A.T., and Duncan R. J. Drug Target. 14 (2006) 375-390
38. Nishiyama N., Yokoyama M., Aoyagi T., Okano T., Sakurai Y., and Kataoka K. Langmuir 15 (1999) 377-383
39. Shuai X., Merdan T., Schaper A.K., Xi F., and Kissel T. Bioconjug. Chem. 15 (2004) 441-448
40. Kataoka K., Matsumoto T., Yokoyama M., Okano T., Sakurai Y., Fukushima S., Okamoto K., and Kwon G.S. J. Control. Release 64 (2000) 143-153
41. Kitaeva M.V., Melik-Nubarov N.S., Menger F.M., and Yaroslavov A.A. Langmuir 20 (2004) 6575-6579
42. Kitaeva M.V., Melik-Nubarov N.S., Menger F.M., and Yaroslavov A.A. Langmuir 20 (2004) 6796-6799
43. Sinha B.K., Mimnaugh E.G., Rajagopalan S., and Myers C.E. Cancer Res. 49 (1989) 3844-3848
44. Kataoka K., Kwon G.S., Yokoyama M., Okano T., and Sakurai Y. J. Control. Release 24 (1993) 119-132
45. Vega J., Ke S., Fan Z., Wallace S., Charsangavej C., and Li C. Pharm. Res. 20 (2003) 826-832